Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ICU MedicalSTU:IC7 80 PEG Ratio is 5.56 as of Aug. 17, 2026, which is 29% above its 10-year median of 4.32. GuruFocus rates STU:IC7 with a GF Score™ of 80/100 and a GF Value™ of €105.79 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 208 Medical Devices & Instruments companies, ICU Medical ranks worse than 81.25% on this metric.
PE Ratio without NRI / 5-Year EBITDA Growth Rate*
PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, ICU Medical's PE Ratio without NRI is 36.11. ICU Medical's 5-Year EBITDA growth rate is 6.50%. Therefore, ICU Medical's PEG Ratio for today is 5.56.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for ICU Medical's PEG Ratio or its related term are showing as below:
STU:IC7'
s PEG Ratio Range Over the Past 10 Years
Min: 1.2 Med: 4.32 Max: 55.5
Current: 5.54
During the past 13 years, ICU Medical's highest PEG Ratio was 55.50. The lowest was 1.20. And the median was 4.32.
STU:IC7's PEG Ratio is ranked worse than 81.25% of 208
companies
in the Medical Devices & Instruments industry
Industry Median: 2.05
vs STU:IC7: 5.54
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
ICU Medical PEG Ratio Related Terms
ICU Medical PEG Ratio Historical Data
* Premium members only.
The historical data trend for ICU Medical's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, ICU Medical's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ICU Medical PEG Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ICU Medical's PEG Ratio distribution charts can be found below:
* The bar in red indicates where ICU Medical's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
ICU Medical (STU:IC7) has a PEG Ratio of 5.56 as of Aug. 17, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on ICU Medical and its competitors. This is 29% above median its historical median of 4.32. Over the past decade, ICU Medical's PEG Ratio has ranged from 1.20 to 55.50. According to the industry distribution chart, ICU Medical ranks #169 out of 208 companies in the Medical Devices & Instruments industry, placing it in the top 81.2%.
Is ICU Medical's PEG Ratio too high?
ICU Medical's current PEG Ratio of 5.56 is 29% above median its 10-year median of 4.32. Over the past 10 years, this metric has ranged from a low of 1.20 to a high of 55.50. The Medical Devices & Instruments industry median PEG Ratio is 2.05. ICU Medical's value of 5.56 is 171.2% above this industry median. Based on the distribution chart, ICU Medical ranks #169 out of 208 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, ICU Medical has a GF Score™ of 80/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does ICU Medical's PEG Ratio compare to NVST and MMSI?
According to the Medical Devices & Instruments industry distribution chart, ICU Medical ranks #169 out of 208 companies for PEG Ratio. This places ICU Medical in the lower half of its industry. The industry median PEG Ratio is 2.05. ICU Medical's value of 5.56 is 171.2% above this benchmark. Historically, ICU Medical's own PEG Ratio has ranged from 1.20 to 55.50 over the past decade. While the company's 10-year median is 4.32 vs. the industry median of 2.05, ICU Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Medical Devices & Instruments company?
The median PEG Ratio among Medical Devices & Instruments companies is 2.05, based on 208 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ICU Medical's current PEG Ratio of 5.56 is 171.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on ICU Medical and its competitors. For the Medical Devices & Instruments industry, the median PEG Ratio is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ICU Medical's current PEG Ratio is 5.56, which is 29% above median its own 10-year median of 4.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ICU Medical stock overvalued right now?
Based on GuruFocus' analysis, ICU Medical (STU:IC7) is currently considered Significantly Overvalued. The stock's GF Value™ is €105.79, compared to a current price of €158.00 — trading 49.4% above its estimated fair value. The current PEG Ratio is 5.56, which is 29% above median its 10-year median of 4.32 and 171.2% above the Medical Devices & Instruments industry median of 2.05. ICU Medical's overall GF Score™ is 80/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For ICU Medical (STU:IC7), the current PEG Ratio is 5.56 as of Aug. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ICU Medical (STU:IC7) Overvalued in 2026?
Based on GuruFocus' analysis, ICU Medical stock appears to be overvalued.
The current stock price of €158.00 is trading 49.4% above its estimated GF Value™ of €105.79.
GuruFocus considers ICU Medical to be Significantly Overvalued.
Key valuation signals for STU:IC7:
PEG Ratio: 5.56 (29% above median its 10-year median of 4.32)
GF Value™: €105.79 vs. price of €158.00 (49.4% above fair value)
Industry Position: 171.2% above the Medical Devices & Instruments median (#169 of 208)
No single metric tells the full story. See the STU:IC7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.
80GF Score
Get the complete analysis for STU:IC7
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:IC7 has been successfully added to your 
